SCHEMBL5166327

SCHEMBL5166327

CN(C)C1(Cc2ccccc2)CCC(NC2CCc3ccccc32)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.45
MAOB P27338 5/20 0.45
BCHE P06276 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
ACHE P22303 1/20 0.45
ADRA1A P35348 1/20 0.45
HTR6 P50406 1/20 0.45
PDPK1 O15530 1/20 0.44
KDM1A O60341 1/20 0.43
OPRM1 P35372 2/20 0.43
OPRL1 P41146 2/20 0.43
OPRK1 P41145 1/20 0.43
CCR2 P41597 1/20 0.41
SLC18A3 Q16572 1/20 0.40
EPHX2 P34913 2/20 0.40
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
GRIN2B Q13224 1/20 0.37
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5167705 0.99 MAOA (0.44) MAOAMAOBBCHEADRA2BADRA2C
Hydrochloric Acid SCHEMBL5165435 0.99 MAOA (0.44) MAOAMAOBBCHEADRA2BADRA2C
SCHEMBL5165737 0.79 OPRL1 (0.51) MAOAMAOBPDPK1KDM1AOPRM1
SCHEMBL5165416 0.79 BCHE (0.50) MAOBBCHEACHEKDM1AOPRM1
SCHEMBL5167763 0.76 OPRM1 (0.54) MAOAMAOBKDM1AOPRM1OPRL1
SCHEMBL207293 0.75 DHODH (0.48)
SCHEMBL205814 0.74 LMNA (0.44) EPHX2
SCHEMBL5165779 0.73 OPRM1 (0.51) MAOAMAOBOPRM1OPRL1OPRK1
SCHEMBL5165079 0.73 OPRM1 (0.65) BCHEACHEOPRM1OPRL1OPRK1
SCHEMBL206834 0.73 DHODH (0.48) EPHX2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392641-B1 SUBSTITUTED CYCLOHEXANE-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2007-04-11 EP claimed
US-7276518-B2 Substituted cyclohexane-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-10-02 US disclosed
EP-1392641-B1 SUBSTITUTED CYCLOHEXANE-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2007-04-11 EP disclosed
US-20040229872-A1 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity GRUENENTHAL GMBH (DE) 2004-11-18 US disclosed
US-20040162287-A1 Substituted cyclohexane-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2004-08-19 US disclosed
EP-1392641-A1 SUBSTITUTED CYCLOHEXANE-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2004-03-03 EP disclosed
EP-1385493-A1 SUBSTITUTED CYCLOHEXAN-1,4-DIAMINE DERIVATIVES WITH CONSTIPATING AND PERIPHERAL ANALGESIC PROPERTIES Grünenthal GmbH (DE) 2004-02-04 EP disclosed
WO-2002089783-A1 SUBSTITUTED CYCLOHEXAN-1,4-DIAMINE DERIVATIVES WITH CONSTIPATING AND PERIPHERAL ANALGESIC PROPERTIES Grünenthal GmbH (DE) 2002-11-14 WO disclosed
WO-2002090317-A1 SUBSTITUTED CYCLOHEXANE-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2002-11-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162287-A1 Substituted cyclohexane-1,4-diamine compounds DPYD, DDC, QDPR MAOA 71/4885MAOB 98/4885BCHE 318/4885
US-20040229872-A1 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity ARG1, CD2, PDCD1 MAOA 2676/4885MAOB 3455/4885BCHE 1002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.